Ultragenyx Pharmaceutical Inc (RARE) USD0.001
1.06%- This stock can be held in a
Stocks and Shares ISASell:$40.28
Buy:$40.40
Change:
$2.01
(5.24%)
$2.01
(5.24%)Prices delayed by at least 15 minutes
Sell:$40.28
Buy:$40.40
Change:$2.01
(5.24%)
$2.01
(5.24%)Prices delayed by at least 15 minutes
Director deals
Listed below are trades carried out by directors and other individuals which are required to be notified to the market.
Recent deals
| Date | Name and position (if held) | Deal type | Number of shares dealt | Price per share | Value of trade | Shares remaining |
|---|---|---|---|---|---|---|
| 6 March 2025 | Howard HornCFO | Sell Tax related | 1,785 | $40.40 | $72,114.00 | 106,169 |
| 3 March 2025 | Emil D KakkisChairman/CEO | Sell Tax related | 73,434 | $42.10 | $3,091,571.40 | 641,731 |
| 3 March 2025 | Thomas Richard (Tom) KassbergExecutive Vice President | Sell Tax related | 6,028 | $42.10 | $253,778.80 | 265,238 |
| 3 March 2025 | Thomas Richard (Tom) KassbergExecutive Vice President | Sell Tax related | 508 | $42.92 | $21,803.36 | 264,730 |
| 3 March 2025 | Dennis Karl HuangCTO | Sell Tax related | 1,348 | $42.92 | $57,856.16 | 114,591 |
| 3 March 2025 | John Richard PinionExecutive Vice President | Sell Tax related | 31 | $42.92 | $1,330.52 | 108,428 |
| 3 March 2025 | John Richard PinionExecutive Vice President | Sell Tax related | 14,439 | $42.10 | $607,881.90 | 107,766 |
| 3 March 2025 | Erik HarrisChief Level Officer | Sell Tax related | 15,103 | $42.10 | $635,836.30 | 87,855 |
| 3 March 2025 | Karah Herdman ParschauerChief Legal/Compliance Officer | Sell Tax related | 12,846 | $42.10 | $540,816.60 | 75,287 |
| 3 March 2025 | Eric CrombezOther Level A | Sell Tax related | 8,945 | $42.10 | $376,584.50 | 71,922 |
5 most significant deals
| Date | Name and position (if held) | Deal type | Number of shares dealt | Price per share | Value of trade | Shares remaining |
|---|---|---|---|---|---|---|
| 3 March 2025 | Emil D KakkisChairman/CEO | Sell Tax related | 73,434 | $42.10 | $3,091,571.40 | 641,731 |
| 3 September 2024 | Emil D KakkisChairman/CEO | Sell Regular sell transaction (market) | 20,000 | $55.85 | $1,117,000.00 | 2,223,985 |
| 28 February 2025 | Emil D KakkisChairman/CEO | Sell Option/Award related | 25,000 | $42.48 | $1,062,000.00 | 2,158,985 |
| 6 August 2024 | Emil D KakkisChairman/CEO | Sell Regular sell transaction (market) | 20,000 | $50.17 | $1,003,400.00 | 2,243,985 |
| 3 March 2025 | Erik HarrisChief Level Officer | Sell Tax related | 15,103 | $42.10 | $635,836.30 | 87,855 |
Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Director deal information provided by Factset.